Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer

British Journal of Cancer

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2dIX9pT
via IFTTT